BASAGLAR
Live / Registered — Registered and renewed (as of 14 Jun 2025)
What this means for you
Registered since 17 Feb 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Feb 2025).
Record
- Serial number
- 85350709
- Registration number
- 4688972
- Mark type
- Stylized text
- Filed
- 20 Jun 2011
- Published for opposition
- 01 Nov 2011
- Registered
- 17 Feb 2015
- Next maintenance due
- 17 Feb 2025
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 14 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Jun 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Jun 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jan 2025 — TEAS SECTION 8 & 9 RECEIVED
- 17 Feb 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 May 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 May 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 May 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Jan 2021 — TEAS SECTION 8 & 15 RECEIVED
- 17 Feb 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Feb 2015 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jan 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Dec 2014 — STATEMENT OF USE PROCESSING COMPLETE